The Results of Surgery, With or Without Radiotherapy, for Primary Spinal Myxopapillary Ependymoma: A Retrospective Study From the Rare Cancer Network-Reference-Cited by-同舟云学术

The Results of Surgery, With or Without Radiotherapy, for Primary Spinal Myxopapillary Ependymoma: A Retrospective Study From the Rare Cancer Network

Published:2009-07 Issue:4 Volume:74 Page:1114-1120
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Pica Alessia,Miller Robert,VillÀ Salvador,Kadish Sidney P.,Anacak Yavuz,Abusaris Huda,Ozyigit Gokhan,Baumert Brigitta G.,Zaucha Renata,Haller Guy,Weber Damien C.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference30 articles.

1. World Health Organization classification of tumors;Kleihues;Cancer,2000

2. MR characteristics of histopathologic subtypes of spinal ependymoma;Kahan;AJNR Am J Neuroradiol,1996

3. Inverse correlation between genetic aberrations and malignancy grade in ependymal tumors: A paradox?;Gilhuis;J Neurooncol,2004

4. Hirose Y, Aldape K, Bollen A, et al. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. 2001;158;1137–1143.

5. Extraspinal ependymoma at the cervicothoracic junction;Yu;Surg Neurol,1982

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Diagnosis to Resolution: A Case Study of Myxopapillary Ependymoma Survival;Cureus;2024-09-02

2. Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era—A Population-Based Observational Study;Cancers;2024-05-25

3. MR-Guided Radiotherapy in the Pediatric and Adolescent Patient;A Practical Guide to MR-Linac;2024

4. Multi-institutional Characterization of Outcomes for Pediatric and Young Adult Patients With High-Risk Myxopapillary Ependymoma After Radiation Therapy;International Journal of Radiation Oncology*Biology*Physics;2023-12

5. PARP inhibition utilized in combination therapy with Olaparib‐Temozolomide to achieve disease stabilization in a rare case of BRCA1‐mutant, metastatic myxopapillary ependymoma;Rare Tumors;2023-01